Skip to content

Efficacy of Local Anesthesic on Diaphragmatic Function After Upper Abdominal Surgery

Efficacy of Parietal Continuous Infiltration of Local Anesthesic on Diaphragmatic Function After Upper Abdominal Surgery Through a Subcostal Incision

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02353702
Acronym
CATPAR
Enrollment
31
Registered
2015-02-03
Start date
2014-07-01
Completion date
2017-06-01
Last updated
2026-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatectomy

Keywords

Diaphragmatic function, sniff-test, pulmonary complications, upper abdominal surgery

Brief summary

Upper abdominal surgery is known to induce such pulmonary complications as pneumonia, atelectasis, pleural effusion. The post operative diaphragmatic dysfunction participates to these complications and lasts for 7 days after upper abdominal surgery. The sniff-test is a recognized tool for measuring the diaphragmatic function.The purpose of this study is to evaluate the effectiveness of parietal analgesia with continuous infiltration of local anesthesic on diaphragmatic function after upper abdominal surgery through a subcostal incision. Our main outcome is to measure the diaphragmatic function with the sniff test in 44 patients with parietal infiltration of ropivacaine and in 44 patients with placebo. Our secondary outcomes are the evaluation of the effect of continuous parietal analgesia with ropivacaine on IPmax and EPmax, oxygen saturation, post operative pulmonary complications and post operative recovery. This prospective study will determine if the pre peritoneal local infiltration of ropivacaine is useful to decrease post operative diaphragmatic dysfunction.

Interventions

PROCEDURESniff test

Evaluation of diaphragmatic function by sniff test after continuous parietal infusion of ropivacaine or placebo

DRUGInfusion of Ropivacaine during 48 hours

20 ml Bolus (7,5 mg/ml) then continuous administration of 10 ml per hour (2 mg/ml) during 48 hours of Ropivacaine. 20 ml Bolus (NaCl 0.9 %) then continuous administration of 10 ml per hour, during 48 hours of NaCl 0.9 %.

DEVICEContinuous parietal infusion with parietal catheter

Continuous parietal infiltration of Ropivacaine or placebo

DRUGInfusion of placebo during 48 hours
DRUGNaCl

Sponsors

University Hospital, Rouen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Surgical Indication for Upper abdominal surgery through subcostal incision * More than 18 years old , less than 80 years old * ASA score between 1 and 3 * Effective contraception for more than 3 months in women of childbearing age * Patients signed an informed consent * Affiliation to a social security regimen

Exclusion criteria

* BMI more than 30 kg/m2 * Nasal obstruction during inclusion * Preoperative treatment with morphine * Need for a postoperative nasogastric tube * Difficulty to understand the use of the PCA and/or the sniff-test * Impossibility to place the catheter in preperitoneal position * Pregnant women or breasting women * Patients under guardianship * Contraindication to use of ropivacaine * Inclusion in another clinical trial

Design outcomes

Primary

MeasureTime frameDescription
Buccal Inspiratory Pression (IP) Evaluation of diaphragmatic function using sniff test.Day 6 post surgeryEvaluation of diaphragmatic function using sniff test. The measured value is buccal inspiratory pression.

Secondary

MeasureTime frameDescription
Maximal buccal inspiratory pression (IPmax) using sniff testDay 6 after surgical procedureEvaluation of maximal buccal inspiratory pression (IPmax) using sniff test
Maximal buccal expiratory pression (EPmax) using sniff testDay 6 after surgical procedureEvaluation of maximal buccal expiratory pression (EPmax) using sniff test
Oxygen saturation rateDay 6 after surgical procedureEvaluation of Oxygen saturation
medical complication outcome (pneumonia)week 6 after surgical procedureMedical pulmonary complications outcome : pneumonia
medical complication outcome (atelectasis)week 6 after surgical procedureMedical pulmonary complications outcome : atelectasis
medical complication outcome (pleural effusions)week 6 after surgical procedureMedical pulmonary complications outcome : pleural effusions
Morphine consummation (Measurement of Morphine consummation since surgery)week 6 after surgical procedure

Countries

France

Contacts

PRINCIPAL_INVESTIGATORMichel SCOTTE, Pr

University Hospital, Rouen

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 30, 2026